Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Caribou Biosciences
4364
Caribou Biosciences
Health Care
Technology
Biotechnology
Medical
Therapeutics
Pioneering the revolutionary field of CRISPR-Cas genome editing to advance therapeutics, agricultural biotech, biological research, and industrial biotech.
Suggest edits
Type
B2c
Founded
2011
Raised
$32.9M
Follow us
Also headquartered in Berkeley
UC Berkeley
Apache Spark
Eko
Everlaw
Pivot Bio
Wildfire
Triton
Grabango
Obviously AI
Bellwether Coffee
Companies in the same industry
Poseida Therapeutics
Betalin Therapeutics Inc
MetaStat Inc.
Aelix Therapeutics
NorthSea Therapeutics
Nuritas
Sensei Biotherapeutics
Seattle Genetics
Immune Design
Wilson Therapeutics
Alexa global traffic share
Twitter followers
Overview
Funding
3
Add info
Latest funding
Show all
$30,000,000
Venture capital (Series B) - 2016
Heritage Group
Novartis
F-Prime Capital Partners
+5
Undisclosed amount
Venture capital - 2015
Novartis
Team Size
10+
Employees
I work here
Location
Berkeley
,
United States
Headquarters
Explore Berkeley
Pulse 2.0
Caribou Biosciences (CRBU) Stock: $28 Price Target From H.C. Wainwright
MedCity News
CRISPR biotech Caribou Biosciences’ IPO reels in $304M for next-gen cell therapy
$30,000,000
Venture capital (Series B)
FinSMEs
Caribou Biosciences Completes $30M Series B Funding
Funding
Science
Venture capital
GEN
GEN | News Highlights:Novartis Launches CRISPR Collaborations with Intellia, Caribou